Processa Pharmaceuticals, Inc.·4

Oct 10, 4:51 PM ET

Stanker James H 4

4 · Processa Pharmaceuticals, Inc. · Filed Oct 10, 2023

Insider Transaction Report

Form 4
Period: 2023-10-10
Stanker James H
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-10-10$0.24/sh+22,500$5,40084,250 total

Documents

1 file
  • 4
    form4.xmlPrimary